Natural YMDD motif mutations in treatment naïve patients with chronic hepatitis B in Huzhou of eastern China.

نویسندگان

  • Fuchu Qian
  • Jiqu Qin
  • Dongli Li
  • Hairong Zhang
  • Zhaowei Tong
  • Weihong Wang
چکیده

amivudine (LAM), a nucleoside analog, was the first anti-HBV rug approved for antiviral therapy in China. Long-term antivial therapy with LAM may lead to drug resistance, which is ssociated with a mutation in tyrosine-methionine-aspartic cid-aspartic acid (YMDD) motif of the reverse transcripase in HBV-DNA genome. Several previous studies showed hat YMDD mutations were also present in treatment-naive hronic hepatitis B (CHB) patients, but the prevalence rates of atural YMDD motif mutations in some reports were quite ifferent (from 0% to 26.9%).1–4 However, the relationship etween natural YMDD motif mutations and virus-related haracteristics in CHB patients is also not quite clear. The aim f present study was to assess the prevalence rate of natual YMDD motif mutations and to investigate the associations etween natural YMDD mutations and clinical factors among AM-untreated CHB patients in Huzhou city, eastern China. A total of 202 CHB patients who had never received antivial treatment were recruited from department of infectious iseases in Huzhou central hospital for this study. CHB was iagnosed according to the Chinese consensus criteria. This tudy was approved by the Ethics Committee of Huzhou cenral hospital. All patients provided written informed consent. erum HBV DNA levels were quantified using a real-time CR kit. HBV genotypes were analyzed by genotype-specific aqman probes using a real-time fluorescence PCR. YMDD utations were detected using specific primers for real-time CR. Natural YMDD mutations were found in 20 (9.9%) treatment aive CHB patients. Among these patients, YVDD variants ere detected in 13 cases, YIDD variants in 5 cases, and VDD + YIDD variants in 2 cases. In this study, the rate f natural YMDD motif mutation was not consistent with revious studies.1–4 The reason for the discrepancy might e due to different demographic characteristics, geographcal diversion, other characteristics of study groups, and ample sizes, as well as sensitivity of different detection ethods.2–4 The mean age of patients were 37.8 ± 10.8 and 36.7 ± 13.2 ears for patients with and without natural YMDD motif, B/C mixed 3 0, 0.0

برای دانلود رایگان متن کامل این مقاله و بیش از 32 میلیون مقاله دیگر ابتدا ثبت نام کنید

ثبت نام

اگر عضو سایت هستید لطفا وارد حساب کاربری خود شوید

منابع مشابه

Frequency of YMDD mutations in patients with chronic hepatitis B untreated with antiviral medicines

 Abstract Background: Investigators were suspicious of tyrosine-methionine-aspartate-aspartate (YMDD) mutations occurred only in patients who were treated by lamivudine. However, YMDD mutations of hepatitis B virus gene (HBV DNA) in patients with chronic hepatitis B (CHB) untreated with antiviral medicines was reported in some studies. The aim of this study was to evaluate YMDD mutations in Ira...

متن کامل

Identification of Drug Resistant Mutants of HBV (Hepatitis B Virus) by Direct Sequencing in Iranian Patients Treated with Lamivudine

Background and Aims: lamivudine is amongst the antiviral for drug chronic hepatitis B treatment. During therapy with lamivudine, variants may emerge with YMDD mutation in the reverse transcriptase (RT) region of polymerase gene. This mutation might have a role in drug resistant for HBV. Materials and Methods: HBV DNA extraction from serum sample of 88 patients, were subjected to nested PCR for ...

متن کامل

YMDD and FLLAQ Mutations in Chronic Hepatitis B Patients

Abstract Background and Objective: Lamivudine is the first orally available drug approved for treatment of chronic hepatitis B. Mutations at the YMDD and FLLAQ motifs in the domains of HBV polymerase gene contribute resistance to lamivudine. This study was aimed to determine the rate of YMDD and FLLAQ mutants in hepatitis B patients in Golestan Province, Iran. Material and methods: In this cros...

متن کامل

The Naturally Occurring YMDD Mutation among Patients Chronically Infected HBV and Untreated with Lamivudine: A Systematic Review and Meta-Analysis

BACKGROUND Several recent reports have demonstrated that tyrosine (Y)-methionine (M)-aspartic acid (D)-aspartic acid (D) (YMDD) motif mutations can naturally occur in chronic HBV patients without antiviral treatment such as lamivudine therapy. This paper aims to assess the overall spontaneous incidence and related risk factors of YMDD-motif mutations among lamivudine-naïve chronic HBV carriers,...

متن کامل

Evaluation of Lamivudine Resistance Mutations in HBV/HIV Co-infected Patients

Background and Objective: The drug resistance mutations are key elements in the failure of long-term treatment of Hepatitis B virus (HBV) and human immunodeficiency virus (HIV) infections. The mutation in the YMDD motif in the P gene of HBV is the most critical factor in antiviral drug (especially lamivudine) resistance. This study aimed to assess the YMDD motif and other polymerase gene mutati...

متن کامل

ذخیره در منابع من


  با ذخیره ی این منبع در منابع من، دسترسی به آن را برای استفاده های بعدی آسان تر کنید

عنوان ژورنال:
  • The Brazilian journal of infectious diseases : an official publication of the Brazilian Society of Infectious Diseases

دوره 20 6  شماره 

صفحات  -

تاریخ انتشار 2016